Journal
JOURNAL OF MOLECULAR LIQUIDS
Volume 340, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.molliq.2021.117182
Keywords
Carbon nanotube; Iron oxide nanoparticle; 5-aminolevulinic acid; DFT; Binding and solvation energy, AIM
Ask authors/readers for more resources
The study examined the binding energies, solvation energies and contributions of different carriers in drug delivery systems, showing that iron oxide nanoparticles have a significant advantage. Quantum molecular descriptors indicated increased reactivity of ALA near carbon nanotubes, functionalized carbon nanotubes, and iron oxide nanoparticles.
Drug delivery systems including the 5-aminolevulinic acid anticancer drug (ALA) and carbon nanotube (CN), COOH functionalized carbon nanotube (FCN) and iron oxide nanoparticle (ION) were examined. For each of the CN, FCN and ION nanocarriers, four (CN/ALA1-4), three (FCN/ALA1-3) and three (ION/ALA1-3) configurations were considered, respectively. All structures were optimized at B3LYP/6-31G(d, p) in aqueous solution. Dispersion corrections were considered using M06-2X density functional. Binding energies, solvation energies and the contribution of each configuration in the drug delivery system were calculated. The binding energies of FCN/ALA1-3 and ION/ALA1-3 are about the same and much larger than those of CN/ALA1-4. On the other hand, the solvation energies of ION/ALA1-3 are more negative than those of CN/ALA1-4 and FCN/ALA1-3, which is an important advantage for iron oxide nanoparticles. Quantum molecular descriptors indicate that the reactivity of ALA increases in the vicinity of CN, FCN and ION. The AIM analysis showed that the hydrogen bonds play important roles in FCN/ALA1-3 and ION/ALA1-3 configurations. (C) 2021 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available